Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1. - Criscuolo E; De Sciscio ML; De Cristofaro A; Nicoara C; Maccarrone M; Fezza F (Pharmaceuticals (Basel, Switzerland), 2023)